Cara Therapeutics | CARA - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Cara Therapeutics USD 14.5M 6.44M 2026-03
Cassava Sciences USD 68.14M 6.26M 2026-03
Chugai Pharma JPY 2.03T 135.62B 2025-12
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 95.35M 7.38M 2026-03
CSL USD 18.66B 2.75B 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
J&J USD 84.97B 3.78B 2026-06
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Pacira USD 671.98M 18.08M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
RedHill Biopharma USD 4.27M 8.68M 2025-12
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12